Back to search
Atypical Ductal Breast Hyperplasia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Ductal Breast Hyperplasia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Ductal Breast Hyperplasia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Inc…
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify…
This phase II trial evaluates tamoxifen, with or without omega-3 fatty acids, for reducing risk of breast cancer among postmenopausal and overweight or obese wo…
This phase IIA trial compares the effect of acolbifene versus low dose tamoxifen in preventing breast cancer in premenopausal women at high risk for developing…
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as wel…
This study evaluates whether adding a polygenic risk score evaluation to standard breast cancer risk assessment tools helps African American and Hispanic women…
This randomized phase III trial studies metformin hydrochloride to see how well it works compared to placebo in preventing breast cancer in patients with atypic…